Centiva Capital »

Moonlake Immunot shares owned by Centiva Capital

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 118k 13.18
2025-09-30 $985k 137k 7.17

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads Put Option (BABA)
Apple Call Option (AAPL)
Pdd Holdings Sponsored Ads Put Option (PDD)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Regeneron Pharmaceuticals Call Option (REGN)
Eli Lilly & Co. Put Option (LLY)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Honeywell International (HON)
Jd.com Spon Ads Cl A (JD)

View all positions for Centiva Capital

Top funds holding Moonlake Immunot

BVF
Deep Track Capital
Cormorant Asset Management
Logos Global Management
Balyasny Asset Management
Jane Street
Adage Capital Partners GP
Susquehanna International
Vivo Capital
Point72 Asset Management
FMR
Nuveen
Hrt Financial
Citadel Advisors
Leucadia National Corporation

View all funds holding Moonlake Immunot